These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20071712)

  • 21. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)].
    Bruj J; Skocil V; Farník J; Hronovský F; Síp J
    Cesk Epidemiol Mikrobiol Imunol; 1981 Sep; 30(5):287-93. PubMed ID: 6456837
    [No Abstract]   [Full Text] [Related]  

  • 22. [The trivalent polymer-subunit influenza vaccine Grippol studied in a controlled epidemiological trial (1)].
    El'shina GA; Masalin IuM; Shervali VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG
    Voen Med Zh; 1996 Aug; 317(8):57-60. PubMed ID: 9036650
    [No Abstract]   [Full Text] [Related]  

  • 23. Recommended composition of influenza virus vaccines for use in the 2012–2013 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2012 Mar; 87(10):83-95. PubMed ID: 22462202
    [No Abstract]   [Full Text] [Related]  

  • 24. Recommended composition of influenza vaccines for use in the 2012 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2011 Oct; 86(42):457-68. PubMed ID: 22046594
    [No Abstract]   [Full Text] [Related]  

  • 25. Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2011 Mar; 86(10):86-90. PubMed ID: 21395187
    [No Abstract]   [Full Text] [Related]  

  • 26. Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2012 Oct; 87(41):389-400. PubMed ID: 23074737
    [No Abstract]   [Full Text] [Related]  

  • 27. Lung transplant patients' T cell responses to influenza vaccine viruses between seasons.
    Hayney MS; Moran J; Wiegert NA; Burlingham WJ
    Vaccine; 2008 May; 26(21):2596-600. PubMed ID: 18420314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003).
    Michiels B; Philips H; Coenen S; Denekens J; Van Royen P
    Vaccine; 2006 Apr; 24(16):3145-52. PubMed ID: 16490288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New options for influenza vaccines: quadrivalent, recombinant, and cell culture.
    Brokhof MM; Foster SL; Hayney MS
    J Am Pharm Assoc (2003); 2013; 53(5):545-9. PubMed ID: 24030133
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommended composition of influenza virus vaccines for use in the 2007 influenza season.
    Wkly Epidemiol Rec; 2006 Oct; 81(41):390-5. PubMed ID: 17039626
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ; Gussekloo J; Remmerswaal JE; Remarque EJ; Kroes AC
    J Med Virol; 2009 May; 81(5):908-14. PubMed ID: 19319953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity.
    Reisinger KS; Block SL; Izu A; Groth N; Holmes SJ
    J Infect Dis; 2009 Sep; 200(6):849-57. PubMed ID: 19673652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine decisions loom for new flu strain.
    Butler D
    Nature; 2009 May; 459(7244):144-5. PubMed ID: 19444174
    [No Abstract]   [Full Text] [Related]  

  • 37. Influenza vaccine 2007-2008.
    Med Lett Drugs Ther; 2007 Oct; 49(1271):81-3. PubMed ID: 17912142
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000-2001 influenza season.
    Kamada M; Nagai T; Kumagai T; Igarashi M; Ihara T; Okafuji T; Ochiai H; Sakiyama H; Shimomura K; Suzuki E; Torigoe S; Miyazaki C; Miyata A; Yuri K; Ito Y; Nakayama T; Kase T; Okuno Y
    Vaccine; 2006 Apr; 24(17):3618-23. PubMed ID: 16530300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.
    Hibbert CL; Piedra PA; McLaurin KK; Vesikari T; Mauskopf J; Mahadevia PJ
    Vaccine; 2007 Nov; 25(47):8010-20. PubMed ID: 17936446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommended composition of influenza virus vaccines for use in the 2014 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2013 Oct; 88(41):437-48. PubMed ID: 24159667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.